Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
about
Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulenceNo detectable effect of RNA-binding protein Hfq absence in Staphylococcus aureusReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsSkin microbiota: a source of disease or defence?Conjugative plasmid transfer in gram-positive bacteriaInvestigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospitalOptical imaging of bacterial infectionsSystematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesMechanisms of vancomycin resistance in Staphylococcus aureusRelationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infectionsA novel gene, fudoh, in the SCCmec region suppresses the colony spreading ability and virulence of Staphylococcus aureusOn the transcriptional regulation of methicillin resistance: MecI repressor in complex with its operatorStructure-Function Studies of the Staphylococcal Methicillin Resistance Antirepressor MecR2Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureusCombinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureusLabel-free, arrayed sensing of immune response to influenza antigens.Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infectionsExploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors.Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects.Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains.Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.Modulation of cell wall synthesis and susceptibility to vancomycin by the two-component system AirSR in Staphylococcus aureus NCTC8325.An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureusPotential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitalsExploring innate glycopeptide resistance mechanisms in Staphylococcus aureusProteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate.Identification of tigecycline- and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran.Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus.Molecular dynamics simulation of the Staphylococcus aureus YsxC protein: molecular insights into ribosome assembly and allosteric inhibition of the protein.Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrataAntimicrobial Resistance and the Alternative Resources with Special Emphasis on Plant-Based Antimicrobials-A ReviewIntensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureusPoly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infectionSeptic arthritis caused by vancomycin-intermediate Staphylococcus aureus.Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus
P2860
Q21131428-A0746F6F-A1B2-44A0-89C4-994A2EE5006BQ21263077-362EB8B8-17F4-4920-B854-0E3911F93D40Q24646677-6E483F8E-D50E-42F0-811A-43A728572D64Q24651518-B52E8BED-9E32-490E-A5BE-9D6C9F0B9515Q24673132-7F5BA308-54B4-4120-8314-7658181495F1Q24810927-273C816A-8A18-45DD-9045-CEC1AF931411Q26747217-598C3686-9549-45B5-9D77-A41398B6AAE8Q26796560-7DE1F7B0-0EC9-408B-8342-3F218C61C868Q26829312-A573A60F-66C7-4DFF-86FE-B01A4C5ADE08Q27011138-AF04EBFC-0015-45C8-B3E8-79A545F65242Q27438134-002FE557-2621-4EE5-BF51-76B59439B178Q27643120-3446E740-0C3A-4A33-B12C-6E9238AA1D07Q27678474-B1DA55AC-8F0C-490B-B0C6-A3DADDE6573BQ28478770-E8B513C1-19A4-436A-83B1-0F50EAF55A07Q28543476-386A0B8F-7BF1-4EFB-BA50-AABC7E95C125Q30397233-D4EA2BFA-1654-4F89-8D34-AC630C43D0F0Q31144203-4B2DEFC4-BAC2-4EA9-9E26-19EFBDF1DF42Q33220466-D2565BE2-D8F9-43A3-B8BC-6578F18AD0D3Q33239640-EBE0EB44-A6B6-46F2-A2B0-7DFE75F375AEQ33263149-488F3B9E-5F4D-4BE8-9566-141875E96B53Q33264418-351D7CE3-8086-47D2-B4A8-6F659E3A50C5Q33321447-201864B7-6E3A-45F9-BFFC-15283CBFBA98Q33432788-95B05C99-336B-4863-B2BD-BE7CE219BF8FQ33554391-A65946E2-B424-40FC-9912-769E7F79CA29Q33557895-185236F4-9777-4747-A533-0194F306E379Q33613735-D97984FE-D1D6-4EA1-BE64-54A05842B66FQ33644173-AE24F800-72F9-44BB-A563-26F32B5175BBQ33723258-7BF2F2AE-6297-4366-9DB3-D170BE9B00D0Q33754549-001EC644-F966-448B-9F75-F49189CFF164Q33762805-AFA0ECD3-A8E5-40E9-8774-2388B1E20470Q33822068-4832170A-DA1B-4FA7-B06F-601077E7A805Q33822841-EE6B6A09-DF47-4D35-BC9F-D584C7A649F0Q33831425-17F59990-22B2-4C03-8CCA-3C3447D069C7Q33832467-9B0B3C57-77C8-4231-9469-CA475B0077B6Q33846718-B409E036-4961-48C8-80DD-BF2DCA1BE848Q33850082-050F3041-DE05-4883-B2EE-C47316172CB2Q33935282-7C1E1FC0-4DB1-478D-B1E0-AA9561636D89Q34033337-2C657E36-070B-41A8-B148-9611A5F76BFBQ34041576-709BA4BB-45B9-485B-BC73-8A478A4B99D4Q34057324-E9148B25-0972-41A7-8ABF-FD9959E1EA86
P2860
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@ast
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@en
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@nl
type
label
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@ast
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@en
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@nl
prefLabel
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@ast
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@en
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@nl
P1476
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
@en
P2093
K Hiramatsu
P304
P356
10.1016/S1473-3099(01)00091-3
P577
2001-10-01T00:00:00Z